CN Stock MarketDetailed Quotes

600211 Tibet Rhodiola Pharmaceutical Holding

Watchlist
  • 35.44
  • -0.16-0.45%
Trading Jan 9 10:45 CST
11.42BMarket Cap15.49P/E (TTM)

Tibet Rhodiola Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tibet Rhodiola Pharmaceutical Holding Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
560.75M
--
+2.37%
EPS
--
0.53
--
--
Analyst Rating
Strong Buy

Jan 8, 2025

Tibet Rhodiola Pharmaceutical Holding Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 4.070B --
-- 2024/FY -- / 3.438B --
Mar 27, 2024 2023/FY 3.134B / 3.506B --
Mar 13, 2020 2019/FY 1.256B / 1.380B --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
--------

Unlock Free Earnings Estimates

Tibet Rhodiola Pharmaceutical Holding Earnings Reports

  • Tibet Nordicang Pharmaceutical Co., Ltd. Report for the third quarter of 2024

    Oct 30, 2024 00:00

  • Tibet Rhodiola Pharmaceutical Holding Semi-annual Report for 2023

    Aug 14, 2024 00:00

  • Summary of Tibet Rhodiola Pharmaceutical Holding's H1 2024 report.

    Aug 14, 2024 00:00

  • Tibet Pharmaceutical Report for the First Quarter of 2024

    Apr 27, 2024 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 8, 2025

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data